IDH1 and central nervous system cancer: Another meta-analysis study found that in low-grade gliomas (WHO grade II), IDH mutation is associated with preoperative tumor-related epilepsy, with an odds ratio (OR) of 2.47 (95% confidence interval [CI], 1.70-3.57), however in higher-grade gliomas (WHO grades III-IV) there was no significant correlation (92).